跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOLU-MEDROL methylprednisolone 500mg (as sodium succinate) powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
SOLU-MEDROL methylprednisolone 500mg (as sodium succinate) powder for injection vial
Approved
STANDARD
SOLU-MEDROL methylprednisolone 500mg (as sodium succinate) powder for injection vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
2c8e056ded75e300
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2c8e056ded75e300
Product Name
SOLU-MEDROL methylprednisolone 500mg (as sodium succinate) powder for injection vial
Artg Id
50691
Artg Name
SOLU-MEDROL methylprednisolone 500mg (as sodium succinate) powder for injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1994-11-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c67ad6a433eba8cf52f0944a9b62240d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2b57451d28ea03ce1ca5c7f513d331fa.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
2c8e056ded75e300
Type
Standard
Back to TGA Approvals